Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Presenting Patient Data and Patient Experience Study for LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting

by merzdev | Apr 23, 2025 | News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces Details of LACRIFILL® Canalicular Gel Poster Presentation At SECO 2025

by merzdev | Feb 28, 2025 | News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024

by merzdev | Oct 17, 2024 | News

Nordic Pharma to share this innovation and its pivotal study article in the Journal of Cataract and Refractive Surgery (JCRS) with ophthalmology leaders. OCTOBER 17, 2024 BERWYN, PA – Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., launched LACRIFILL...

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye

by merzdev | May 29, 2024 | News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting

by merzdev | Apr 2, 2024 | News